#United States #New York #Class Action #Gross Law Firm #Alto Neuroscience

Important Announcement for Alto Neuroscience, Inc. Shareholders

On August 14, 2025, The Gross Law Firm released a crucial notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). This notification comes as part of an ongoing class action lawsuit that could impact investors significantly. If you purchased shares of ANRO during the designated class period, it is imperative that you pay attention to the details provided.

Class Period Details

The class action lawsuit involves all individuals and entities who acquired Alto Neuroscience common stock within a specific timeframe. This period is detailed as follows:

• - Initial Public Offering Date: February 2, 2024
• - Class Period Duration: February 2, 2024, to October 22, 2024 (both dates inclusive)

If you were one of the shareholders who bought ANRO shares during this window, you are strongly encouraged to reach out to The Gross Law Firm concerning a potential lead plaintiff appointment. It's essential to note that becoming a lead plaintiff is not a requirement for participating in any recovery from this lawsuit.

Allegations Against Alto Neuroscience

The lawsuit alleges that during the specified class period, Alto Neuroscience and its representatives made several materially false and misleading statements regarding the effectiveness and prospects of their treatment product according to clinical data presented. The core allegations include:
1. The company's product pipeline, particularly ALTO-100, was misrepresented as more effective in treating major depressive disorder than was actually the case.
2. Claims regarding the clinical, regulatory, and commercial prospects of ALTO-100 were exaggerated.
3. The ramifications of these misleading statements culminated in an inflated perception of Alto's business and financial health, misleading investors and inflating stock prices unjustly.
4. Consequently, the company's public statements were found to be materially false and misleading throughout the class period.

Important Deadlines for Shareholders

To secure your position in this matter, it is crucial to act swiftly. The deadline for shareholders wishing to seek lead plaintiff status is September 19, 2025. Waiting could hinder your chances for recovery. To register your information as a shareholder who purchased ANRO shares during the specified timeframe, you can visit the following link: Register Here

By registering, you'll also gain access to a portfolio monitoring software that will provide updates about the case as it progresses.

Why Choose The Gross Law Firm?

The Gross Law Firm is a prestigious class action law firm recognized nationwide for its dedication to protecting investor rights. Their mission is to hold companies accountable for fraudulent or misleading practices that adversely affect shareholder interests. The firm is committed to pursuing recovery on behalf of investors whose losses stemmed from such negligence.

Moreover, representation by The Gross Law Firm entails no upfront financial obligations; they work on a contingency basis, meaning they only get paid if you do. This offers a level of financial security and reduces the risks associated with participating in such legal matters.

Contact Information

For more details and to participate in this significant class action, shareholders can reach The Gross Law Firm directly at:

• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

In conclusion, if you have invested in Alto Neuroscience, now is the time to act. The deadlines are fast approaching, and your rights as an investor are worth protecting. Taking the necessary steps now can significantly impact your recovery in the face of alleged misleading practices by the company.